Ms. Christy K Anderson, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 7785 Saint Gertrude Ave, Raleigh, ND 58564 Phone: 701-597-3419 |
Ms. Laura Jean Alcala, LAC, LADC, MFT-I Counselor Medicare: Not Enrolled in Medicare Practice Location: 7785 Saint Gertrude Ave, Raleigh, ND 58564 Phone: 701-597-3419 |
Aimee Reidy Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 7785 Saint Gertrude Ave, Raleigh, ND 58564 Phone: 701-597-3419 |
Stephanie Ann Isaak, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7785 Saint Gertrude Ave, Raleigh, ND 58564 Phone: 701-597-3419 |
News Archive
KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.
New research on the bed bug's ability to withstand the genetic bottleneck of inbreeding, announced today at the American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting, provides new clues to explain the rapidly growing problem of bed bugs across the United States and globally.
A leading Australian eye expert has warned that people who do not adopt a healthy life style can expect a loss of vision in later life.
It turns out that the type, how frequent, and where new mutations occur in the human genome depends on which DNA building blocks are nearby, found researchers from the Perelman School of Medicine at the University of Pennsylvania in an advanced online study published this week in Nature Genetics.
A pre-procedure bleeding risk score can accurately identify high-risk, high-cost patients and may provide an opportunity to employ bleeding avoidance strategies to improve patient outcomes and reduce total costs related to percutaneous coronary intervention (PCI) procedures, according to a retrospective study being presented March 26 at the 61st annual American College of Cardiology (ACC) scientific session.
› Verified 8 days ago